Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer.
Porter R, Bockorny B, Corr BR, Mahadevan D, Wilky BA, El-Khoueiry AB, Bullock AJ, Hafez N, Moser J, Martynova A, Stebbing J, Joshi B, Bourdelais S, Delepine C, Chand D, Wu W, Johnson B, Grossman JE, O'Day SJ, Matulonis UA, Gordon MS. Porter R, et al. Among authors: mahadevan d. J Immunother Cancer. 2025 Dec 23;13(12):e013222. doi: 10.1136/jitc-2025-013222. J Immunother Cancer. 2025. PMID: 41436232 Free PMC article. Clinical Trial.
Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors.
Mahadevia H, Majeed U, Patel J, Ahmed AK, Elhariri A, Albelal D, Rao NNM, Rachamala HK, Mosalem O, Mukhopadhyay D, Jones J, Mahadevan D, Borad MJ, Ahn D, Sonbol MB, Tran N, Mahipal A, Wee Ma W, McWilliams RR, Halfdanarson TR, Kankeu Fonkoua LA, Bekaii-Saab T, Mody K, Babiker H. Mahadevia H, et al. Among authors: mahadevan d. JAMA Netw Open. 2025 Sep 2;8(9):e2531373. doi: 10.1001/jamanetworkopen.2025.31373. JAMA Netw Open. 2025. PMID: 40938601 Free PMC article.
Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas.
Wilky BA, Schwartz GK, Gordon MS, El-Khoueiry AB, Bullock AJ, Henick B, Agulnik M, Singh A, Mahadevan D, Stebbing J, Delepine C, Chand D, Avagyan M, Wu W, Johnson B, Grossman JE, O'Day S, Trent JC, Jones RL, Tsimberidou AM. Wilky BA, et al. Among authors: mahadevan d. J Clin Oncol. 2025 Apr 10;43(11):1358-1368. doi: 10.1200/JCO-24-02524. Epub 2025 Jan 27. J Clin Oncol. 2025. PMID: 39869830 Free PMC article. Clinical Trial.
The local molecular signature of human peripheral neuropathic pain.
Sandy-Hindmarch OP, Chang PS, Scheuren PS, De Schoenmacker I, Hubli M, Loizou C, Wirth S, Mahadevan D, Wiberg A, Furniss D, Calvo M, Bennett DLH, Denk F, Baskozos G, Schmid AB. Sandy-Hindmarch OP, et al. Among authors: mahadevan d. Pain. 2025 May 1;166(5):1143-1156. doi: 10.1097/j.pain.0000000000003472. Epub 2024 Nov 25. Pain. 2025. PMID: 39588776 Free PMC article.
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.
Bullock AJ, Schlechter BL, Fakih MG, Tsimberidou AM, Grossman JE, Gordon MS, Wilky BA, Pimentel A, Mahadevan D, Balmanoukian AS, Sanborn RE, Schwartz GK, Abou-Alfa GK, Segal NH, Bockorny B, Moser JC, Sharma S, Patel JM, Wu W, Chand D, Rosenthal K, Mednick G, Delepine C, Curiel TJ, Stebbing J, Lenz HJ, O'Day SJ, El-Khoueiry AB. Bullock AJ, et al. Among authors: mahadevan d. Nat Med. 2024 Sep;30(9):2558-2567. doi: 10.1038/s41591-024-03083-7. Epub 2024 Jun 13. Nat Med. 2024. PMID: 38871975 Free PMC article. Clinical Trial.
Gene Expression Patterns Associated with Survival in Glioblastoma.
Morrison C, Weterings E, Gravbrot N, Hammer M, Weinand M, Sanan A, Pandey R, Mahadevan D, Stea B. Morrison C, et al. Among authors: mahadevan d. Int J Mol Sci. 2024 Mar 25;25(7):3668. doi: 10.3390/ijms25073668. Int J Mol Sci. 2024. PMID: 38612480 Free PMC article.
197 results